Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides

FEBS Lett. 2001 Sep 21;505(3):348-52. doi: 10.1016/s0014-5793(01)02788-0.

Abstract

AMP-activated protein kinase (AMPK) is known to be activated by phosphorylation on Thr172 in response to an increased AMP/ATP ratio. We report here that such an activation indeed occurred in anaerobic rat hearts and that it was antagonized (40-50%) when the hearts were pre-treated with 100 nM insulin. The effect of insulin (1) was blocked by wortmannin, an inhibitor of phosphatidylinositol-3-kinase; (2) only occurred when insulin was added before anoxia, suggesting a hierarchical control; (3) resulted in a decreased phosphorylation state of Thr172 in AMPK and (4) was unrelated to changes in the AMP/ATP ratio. This is the first demonstration that AMPK activity could be changed without a detectable change in the AMP/ATP ratio of the cardiac cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases
  • Adenosine Monophosphate / metabolism
  • Adenosine Triphosphate / metabolism
  • Animals
  • Cell Hypoxia*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Insulin / pharmacology*
  • Male
  • Multienzyme Complexes / antagonists & inhibitors*
  • Multienzyme Complexes / metabolism
  • Myocardial Ischemia / metabolism*
  • Myocardium / cytology
  • Myocardium / enzymology
  • Myocardium / metabolism
  • Protein Serine-Threonine Kinases / antagonists & inhibitors*
  • Protein Serine-Threonine Kinases / metabolism
  • Rats
  • Rats, Wistar

Substances

  • Enzyme Inhibitors
  • Insulin
  • Multienzyme Complexes
  • Adenosine Monophosphate
  • Adenosine Triphosphate
  • Protein Serine-Threonine Kinases
  • AMP-Activated Protein Kinases